A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2004
10/07/2004	US20040197335 Non-myeloablative tolerogenic treatment with tyrphostins
10/07/2004	US20040197309 Schwann cells originating in myeloid interstitial cells
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	US20040194793 Coated nicotine-containing chewing gum, manufacture and use thereof
10/07/2004	CA2520251A1 Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines
10/07/2004	CA2519681A1 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
10/07/2004	CA2519051A1 Water-soluble thalidomide derivatives
10/07/2004	CA2518945A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
10/07/2004	CA2518854A1 Treating immunological disorder using agonists of interleukin-21/interleukin-21 receptor
10/06/2004	EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases
10/06/2004	EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp
10/06/2004	EP1464645A1 Indole derivative
10/06/2004	EP1464641A1 4-Phenyl-piperazinyl, -piperidinyl and tetrahydropyridyl derivatives as dopamine D4 antagonists
10/06/2004	EP1464337A1 Regulation of intracellular glucocorticoid concentrations
10/06/2004	EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
10/06/2004	EP1464332A1 Combination of nicergoline and riluzole for the prevention and treatment of motoneuronal disorders
10/06/2004	EP1463830A2 Method for classification of anti-psychotic drugs
10/06/2004	EP1463823A2 Methods of increasing endogenous erythropoietin (epo)
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463806A2 Novel cyclooxygenase variants and methods of use
10/06/2004	EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004	EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463754A2 Cystine-knot fold protein
10/06/2004	EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use
10/06/2004	EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004	EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents
10/06/2004	EP1463723A1 Process for the preparation of simvastatin
10/06/2004	EP1463722A2 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2-H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES
10/06/2004	EP1463721A1 Compounds for imaging alzheimer's disease
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463713A1 Prodrugs of excitatory amino acids
10/06/2004	EP1463711A1 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
10/06/2004	EP1463530A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
10/06/2004	EP1463528A1 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain
10/06/2004	EP1463527A2 The use of gammaglobulin for the treatment of immune-mediated diseases
10/06/2004	EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463503A1 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
10/06/2004	EP1463499A1 Method for treating circadian rhythm disruptions
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004	EP1463487A1 Liposomal delivery of vitamin e based compounds
10/06/2004	EP1463481A2 Methods and compositions for treatment of central nervous system disorders
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/06/2004	EP1379262B1 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
10/06/2004	EP1326832B1 Chemical compounds
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1232141B1 Ethers of o-desmethyl venlafaxine
10/06/2004	EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use
10/06/2004	EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1133284B1 A process for the preparation of crystalline particles
10/06/2004	EP1037892B1 Piperidine derivatives
10/06/2004	EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004	EP1018878B1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
10/06/2004	EP0918772B1 Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535274A Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene
10/06/2004	CN1535273A Novel 2,5-diazabicyclo [2.2.1] heptane derivatives
10/06/2004	CN1535268A Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
10/06/2004	CN1535267A 5-membered heterocycles, preparation and use thereof as medicine
10/06/2004	CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II
10/06/2004	CN1535168A Controlled release composition and method of producing the same
10/06/2004	CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries
10/06/2004	CN1535157A West nile vaccine
10/06/2004	CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004	CN1535152A Use of bisphosphonates for pain treatment
10/06/2004	CN1535150A Novel use of 2-[5-(40fluorophenyl)3-pyridylmethylaminomethyl]
10/06/2004	CN1535148A Imidazole derivatives for moudlating sodium channels
10/06/2004	CN1535146A 5-halo-tryptamine derivatives used as ligands of 5-HT 6 and/or 5-HT7 serotonin receptors
10/06/2004	CN1535142A Transdermal patch for administering fentanyl
10/06/2004	CN1534035A Water soluble thalidomide derivrative
10/06/2004	CN1534023A Heterocyclic compound as dopamine-D3ligand
10/06/2004	CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004	CN1533789A Medicine for giving up toxin and its preparation method
10/06/2004	CN1533769A Compound melatonin health care food
10/06/2004	CN1169824C Polytype gene of MXA protein and application thereof
10/06/2004	CN1169822C Quercetin derivative and its medicinal use
10/06/2004	CN1169811C Method for synthesizing (3aS)-5,5-dioxo-2,3,3a,4-tetrahydric-1H-pyrrolo [2,1-c][1,2,4] benzodiazine
10/06/2004	CN1169808C 'Beta'-carboline compound
10/06/2004	CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases
10/06/2004	CN1169559C Medical Liquor for treating rheuamtic arthritis ischias, etc
10/06/2004	CN1169558C Medicine for treating depression and its prepn method
10/06/2004	CN1169550C Chinese medicine powder for treating epilepsy
10/06/2004	CN1169545C Traditional Chinese medicine prepn. for treating mental hypoevolutismus and senile dementia
10/06/2004	CN1169536C Capsule for treating depression
10/06/2004	CN1169532C Liquor for treating rheumatism and arthritis
10/05/2004	US6800761 Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
10/05/2004	US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004	US6800653 Anticancer agents
10/05/2004	US6800651 Potentiators of glutamate receptors
10/05/2004	US6800648 Schizophrenia, bipolar disorders, parkinson's disease; drug abruse
10/05/2004	US6800645 Substituted azabicyclic compounds

1 ... 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 ... 1833